These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 29935878)
41. Beyond an Obvious Cause of Cholestasis in a Toddler: Compound Heterozygosity for Fotoulaki M; Giza S; Jirsa M; Grammatikopoulos T; Miquel R; Hytiroglou P; Tsitouridis I; Knisely AS Pediatrics; 2019 May; 143(5):. PubMed ID: 31015375 [TBL] [Abstract][Full Text] [Related]
42. Excessive bilirubin elevation in a patient with hereditary spherocytosis and intrahepatic cholestasis. Wree A; Canbay A; Müller-Beissenhirtz H; Dechêne A; Gerken G; Dührsen U; Lammert F; Nückel H Z Gastroenterol; 2011 Aug; 49(8):977-80. PubMed ID: 21811948 [TBL] [Abstract][Full Text] [Related]
43. Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression. Vanwijngaerden YM; Wauters J; Langouche L; Vander Perre S; Liddle C; Coulter S; Vanderborght S; Roskams T; Wilmer A; Van den Berghe G; Mesotten D Hepatology; 2011 Nov; 54(5):1741-52. PubMed ID: 21800341 [TBL] [Abstract][Full Text] [Related]
45. Adenovirus-mediated human aquaporin-1 expression in hepatocytes improves lipopolysaccharide-induced cholestasis. Marrone J; Danielli M; Gaspari CI; Marinelli RA IUBMB Life; 2017 Dec; 69(12):978-984. PubMed ID: 29087027 [TBL] [Abstract][Full Text] [Related]
46. Clinical, Pathologic, and Genetic Features of Neonatal Dubin-Johnson Syndrome: A Multicenter Study in Japan. Togawa T; Mizuochi T; Sugiura T; Kusano H; Tanikawa K; Sasaki T; Ichinose F; Kagimoto S; Tainaka T; Uchida H; Saitoh S J Pediatr; 2018 May; 196():161-167.e1. PubMed ID: 29499989 [TBL] [Abstract][Full Text] [Related]
47. Reduced hepatic expression of farnesoid X receptor in hereditary cholestasis associated to mutation in ATP8B1. Alvarez L; Jara P; Sánchez-Sabaté E; Hierro L; Larrauri J; Díaz MC; Camarena C; De la Vega A; Frauca E; López-Collazo E; Lapunzina P Hum Mol Genet; 2004 Oct; 13(20):2451-60. PubMed ID: 15317749 [TBL] [Abstract][Full Text] [Related]
48. Hepatic gene transfer of human aquaporin-1 improves bile salt secretory failure in rats with estrogen-induced cholestasis. Marrone J; Soria LR; Danielli M; Lehmann GL; Larocca MC; Marinelli RA Hepatology; 2016 Aug; 64(2):535-48. PubMed ID: 26999313 [TBL] [Abstract][Full Text] [Related]
49. Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport. Paulusma CC; Groen A; Kunne C; Ho-Mok KS; Spijkerboer AL; Rudi de Waart D; Hoek FJ; Vreeling H; Hoeben KA; van Marle J; Pawlikowska L; Bull LN; Hofmann AF; Knisely AS; Oude Elferink RP Hepatology; 2006 Jul; 44(1):195-204. PubMed ID: 16799980 [TBL] [Abstract][Full Text] [Related]
50. [Diagnostic values of lactate dehydrogenase (LDH), creatine kinase (CK) and gamma-glutamyltransferase (gamma-GT) examinations in the course of intrahepatic cholestasis in pregnancy]. Czajkowski K; Wójcicka-Jagodzińska J; Romejko E; Smolarczyk R; Kostro I; Teliga-Czajkowska J; Malinowska-Polubiec A; Mrozek J Ginekol Pol; 2001 Oct; 72(10):791-6. PubMed ID: 11848015 [TBL] [Abstract][Full Text] [Related]
51. Characterization and treatment of persistent hepatocellular secretory failure. van Dijk R; Kremer AE; Smit W; van den Elzen B; van Gulik T; Gouma D; Lameris JS; Bikker H; Enemuo V; Stokkers PC; Feist M; Bosma P; Jansen PL; Beuers U Liver Int; 2015 Apr; 35(4):1478-88. PubMed ID: 24905729 [TBL] [Abstract][Full Text] [Related]
52. BSEP: function and role in progressive familial intrahepatic cholestasis. Thompson R; Strautnieks S Semin Liver Dis; 2001 Nov; 21(4):545-50. PubMed ID: 11745042 [TBL] [Abstract][Full Text] [Related]
53. Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies. Wang R; Liu L; Sheps JA; Forrest D; Hofmann AF; Hagey LR; Ling V Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G286-94. PubMed ID: 23764895 [TBL] [Abstract][Full Text] [Related]
54. Trafficking and transporter disorders in pediatric cholestasis. Knisely AS; Gissen P Clin Liver Dis; 2010 Nov; 14(4):619-33. PubMed ID: 21055686 [TBL] [Abstract][Full Text] [Related]
55. Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4-phenylbutyrate. Gonzales E; Grosse B; Schuller B; Davit-Spraul A; Conti F; Guettier C; Cassio D; Jacquemin E Hepatology; 2015 Aug; 62(2):558-66. PubMed ID: 25716872 [TBL] [Abstract][Full Text] [Related]
59. [Recurrent intrahepatic cholestasis of pregnancy and chain-like choledocholithiasis in a female patient with stop codon in the ABDC4-gene of the hepatobiliary phospholipid transporter]. Muehlenberg K; Wiedmann K; Keppeler H; Sauerbruch T; Lammert F Z Gastroenterol; 2008 Jan; 46(1):48-53. PubMed ID: 18188816 [TBL] [Abstract][Full Text] [Related]
60. Genetics and Molecular Modeling of New Mutations of Familial Intrahepatic Cholestasis in a Single Italian Center. Giovannoni I; Callea F; Bellacchio E; Torre G; De Ville De Goyet J; Francalanci P PLoS One; 2015; 10(12):e0145021. PubMed ID: 26678486 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]